港股異動 | 百濟神州(6160.HK)漲超7% 即將放榜+機構唱好
格隆匯2月25日丨百濟神州(6160.HK)大幅拉昇反彈7.57%,報130.8港元,暫成交1485萬港元,總市值1742億港元。日前公司宣佈澤布替尼新適應症的上市許可申請在美國和歐洲獲得受理。憑藉優異的療效和出色的商業運作能力,澤布替尼獲得了海外市場的廣泛認可,商業化進程的節奏較快。中信證券預計2022年澤布替尼、替雷利珠單抗、Ociperlimab等重磅產品均有多項里程碑事件落地,公司業績有望加速提升。據悉,布替尼已在44 個市場獲批,覆蓋美國、中國、歐盟、澳大利亞等多個國家或地區,展現出了巨大的市場潛力。此外,公司將於今日放榜,隨着多項臨牀管線成果逐步落地,公司的業績有望加速提升。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.